US$ 23.50
amgen glp-1 drug candidate side effects The enormous popularity of new weight-loss drugs often eclipses the downsides: the burden of weekly injections, rough gastrointestinal effects, muscle and bone loss. That is shaping a race among manufacturers Progress on Amgen's Weight Loss
Description
Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
GLP-1 weight loss treatments can come with side effects

Antiamyloid therapies have recently changed the treatment landscape

If youve heard about GLP-1 medications like Wegovy, Zepbound,or Saxenda, you know they help people lose weight by reducing appetite and slowing digestion
